PTC299
PTC299 is an orally bioavailable small molecule that selectively inhibits VEGFA protein synthesis post-transcriptionally and potently targets dihydroorotate dehydrogenase (DHODH) . It has been investigated in preclinical in vitro and in vivo studies for its potential application in angiogenesis-dependent research areas, including oncology.
Product Specifications
CAS Number
1256565-36-2
Product Name Alternative
Field of Research
Cardiovascular Research, Cell Biology, Metabolism Research, Molecular Biology, Signal Transduction
Purity
99.19% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween-80+45% Saline:1 mg/mL (2.14 mM) ; DMSO:50 mg/mL (106.99 mM)
Smiles
COc1ccc (cc1) [C@@H]1N (CCc2c1[nH]c1ccc (Cl) cc21) C (=O) Oc1ccc (Cl) cc1
Molecular Formula
C25H20Cl2N2O3
Molecular Weight
467.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog